Evolent Health to Acquire Valence Health, Extending Breadth and Depth of Value-Based Care Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Leerink Partners Remains Bullish on Evolent Health (EVH) Following Investor Call
July 13, 2016 1:31 PM EDTLeerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with investors. On the call management highlighted that they would expect Valence to continue to grow in the ~30% range in 2017. Management also believes that their... More
FBR Capital Raises Price Target on Evolent Health (EVH) to $24 Following Valence Health Acquisitions
July 13, 2016 11:16 AM EDTFBR Capital reiterated an Outperform rating on Evolent Health (NYSE: EVH), and raised the price target to $24.00 (from $16.00), following the company's announced acquisition of most of the assets of Valence Health. In addition to bringing new expertise, EVH will benefit from using Valent for... More
